World Sight Day: Optos is Saving Sight and Saving Lives

Posted on October 13th, 2016 by
Optos' Patient Stories

World Sight Day is an annual day of awareness held on the second Thursday of October, to focus global attention on blindness and vision impairment. World Sight Day 2016 takes place October 13. This year’s theme and call to action is “Stronger Together,” encouraging a focus on all stakeholders who are important for successful delivery of eyecare – Optos being one of those stakeholders.


Optos plc has the vision to be The Retina Company and is recognized as a leading provider of devices to eyecare professionals for improved patient care. Optos was founded and incorporated in 1992 by Douglas Anderson after his then five-year-old son went blind in one eye because a retinal detachment was detected too late. Although his son was having routine eye exams, the exams were uncomfortable, and difficult for a child to sit still through, which made it impossible for his eye doctor to conduct a complete exam and view the entire retina. Anderson’s mission was to commercialize a patient-friendly, easy to use and comfortable retinal imaging product that encompassed a digital widefield image of the retina in a single capture. Fast forward to 1999: the P200 received both 510k clearance from the FDA and the EU CE marking. Optos devices have been sold worldwide since …

October is Home Eye Safety and Eye Injury Prevention Month

Posted on October 4th, 2016 by
October is Home Eye Safety and Eye Injury Prevention Month

In a world where the calendar is jammed with awareness months, should home eye safety and injury prevention really demand our attention? The answer is crystal clear. With two million eye injuries taking place each year in the United States1, eye safety is something in which everyone has a stake. Let’s look at the numbers:


— The U.S. Eye Injury Registry estimates that each year Americans suffer over two million eye injuries.


— The American Academy of Ophthalmology2 and the American Society of Ocular Trauma report that close to 45% of these injuries take place at home.


— Over 40% of eye injuries were caused by work related to home repairs, yard work, cleaning and cooking. Another 40% occurred during sports or recreation.


— Over one-third of injuries took place in the living areas in the home – places like the kitchen, bathroom, bedroom, and family room.


— There are 125,000 eye accidents a year involving household chemicals3. This totals over 10% of the total at-home eye injuries.


What’s even more sobering? It’s estimated that 90% of eye injuries can be prevented.


Building Public Awareness about Eye Injury at Home


Statistics like these explain why …

Ultra-widefield Imaging is Changing Patient Management

Posted on September 29th, 2016 by
Top: Diabetic Retinopathy, California - Courtesy of Paulo Stanga, MD. Bottom: Retinopathy of Prematurity, Daytona, Proviewed

In case studies, peer-reviewed papers, and a growing body of real-world practice, the ocular health community is improving patient management with the wider use of ultra-widefield (UWF™) imaging. Like all diagnostic breakthroughs, adoption of UWF imaging has been a long term process, paced by the accumulation of validated clinical experience. But now, more than a decade after UWF imaging was first introduced, the evidence is overwhelming that UWF imaging may have the potential to improve the diagnosis and management of a significant group of ocular diseases and conditions.



UWF imaging technology captures a 200-degree image of the retina – which enables ocular health practitioners to capture peripheral retinal images that can not be captured with conventional imaging methods. Starting with color (red and green) optomap imaging, Optos has systematically extended its UWF-based technology into a multi-modal platform that supports fundus autofluorescence (optomap af), fluorescein angiography (optomap fa) and indocyanine green angiography (optomap icg).


Where does UWF imaging have potential to improve diagnosis and treatment?


Proliferative Sickle Cell Retinopathy (PSR)


In a first of its kind case study1, researchers used multi-mode UWF imaging to examine the vascular changes associated with PSR, a complication of sickle cell disease that impacts the retinal …

How UWF Imaging is Improving the Management of Sickle Cell Retinopathy

Posted on September 23rd, 2016 by
Sickle Cell Retinopathy FA

Recent research suggests that patients suffering from various systemic disorders may have their disease state impacted by the addition of ultra-widefield (UWF™) retinal imaging to their examination.  New research has found that patients with sickle cell disease may benefit from UWF retinal imaging for the diagnosis and management of sickle cell retinopathy (SCR).





Sickle cell disease is an inherited disorder in which the body produces blood cells with abnormally formed hemoglobin. Symptoms include anemia, severe and chronic pain, infection, hypertension, hand and foot swelling, leg ulcers, and retinal vascular changes1. Sickle cell disease can also have an impact on vision. Sickle cell retinopathy mainly affects the peripheral retinal vasculature2 as the result of abnormal, sickle-shaped blood cells becoming trapped in the small blood vessels of the eye3. Non-proliferative SCR, characterized by retinal hemorrhage from superficial blood vessels, can cause loss of visual acuity. Proliferative SCR is marked by vascular occlusions that lead to localized ischemia, neovascularization, and in later stages blindness from vitreous hemorrhage or tractional retinal detachment. Patients with sickle cell disease are at varying degrees of risk of developing SCR, but those with the type SC or S-Thal hemoglobin genotypes are at significant risk for developing …

Ultra-widefield Fundus Imaging: Clinical Applications and Future Developments

Posted on August 15th, 2016 by
optomap - A comprehensive review published in Retina describes how ultra-widefield (UWF) is evolving to become the standard of care imaging modality for many diseases and is finding new clinical and research applications such as for screening and telemedicine.

Over the past decade Optos has expanded the capability of its core ultra-widefield fundus imaging technology, and with that has come a widening number of clinical applications.

Ultra-widefield (UWF™) imaging technology – enabling the capture of a 200-degree view of the retina without dilation – gives ocular health practitioners imagery and diagnostic information that can’t be provided by conventional imaging methods. Starting with color (red and green) optomap imaging, Optos has systematically extended its UWF-based technology into a multi-modal platform that supports fundus autofluorescence (optomap af), fluorescein angiography (optomap fa) and indocyanine green angiography (optomap icg).



Optos has also been incorporating the latest developments in image processing, providing users with important diagnostic and treatment management tools. In its latest software release, Optos has incorporated an advanced, proven stereographic projection algorithm that corrects for peripheral image variations that occur when a spherical image is flattened.


Clinical Applications


While the most common use of UWF technology may be in the diagnosis and treatment of diabetic retinopathy (DR), optomap imaging is also being used for characterizing pediatric retinal disease; age-related macular degeneration (AMD); retinal breaks and tears; uveitis, ocular oncology; central serous chorioretinopathy (CSCR); retinal vein occlusion (RVO); and a growing list of other …